Clinical trial
Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced…
NCT00415116 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00415116 |
|---|---|
| Title | Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Trial of Three-Weekly Docetaxel, Carboplatin and Oral CC-5013 in Patients With Advanced Solid Tumors |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | carboplatin, docetaxel, lenalidomide |
| Enrollment | 14 |
| Start date | Aug 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Dec 22, 2006 |
| Last update posted | Jul 8, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: